In the following video, Motley Fool health-care analyst David Williamson highlights one critical asset for pharmaceutical company Celgene (NASDAQ:CELG) -- its management. He gives investors three factors that he sees as essential for the leader of any pharmaceutical company, and tells us how well Celgene's Chairman and CEO Bob Hugin stacks up to those criteria.